Ensign Peak Advisors
RXST icon

Ensign Peak Advisors’s RxSight RXST Stock Holding History

Ensign Peak Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-118,928
Closed -$1.07M – 1725
2025
Q3 		$1.07M Sell
118,928
-40,172
-25% -$353K ﹤0.01% 1007
2025
Q2 		$2.07M Sell
159,100
-46,814
-23% -$704K ﹤0.01% 895
2025
Q1 		$5.2M Buy
205,914
+73,030
+55% +$2.17M 0.01% 627
2024
Q4 		$4.57M Buy
132,884
+27,913
+27% +$1.26M 0.01% 667
2024
Q3 		$5.19M Buy
104,971
+44,403
+73% +$2.27M 0.01% 615
2024
Q2 		$3.64M Buy
60,568
+53,571
+766% +$3.06M 0.01% 712
2024
Q1 		$361K Buy
+6,997
New +$343K ﹤0.01% 1677

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Ensign Peak Advisors's RXST Position: Q4 2025 in Review

Ensign Peak Advisors sold out of RxSight (RXST) in Q4 2025, closing a stake of 118,928 shares — an estimated $1.07M sold.

Ensign Peak Advisors first reported a position in RXST in Q1 2024 and held it in 7 quarters. The position peaked at $5.2M in Q1 2025. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

  • Ensign Peak Advisors reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 118,928 RxSight shares in Q4 2025, an estimated $1.07M.
  • Ensign Peak Advisors first reported a position in RxSight in Q1 2024 and held it in 7 quarters.
  • Ensign Peak Advisors's RxSight position peaked at $5.2M in Q1 2025.
  • 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.